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Dear Editor, 
Considering the severe outcome of undiagnosed 
ophthalmic brucellosis, the timely recognition of 
this form of disease could prevent its further com-
plications.
1 The first case of ophthalmic brucello-
sis was reported by Lemaire in 1924.
2 The eye 
involvement in brucellosis occurs in different 
forms including dacryoadenitis, conjunctivitis, 
episcleritis, keratitis, iritis, iridocyclitis, neuroreti-
nitis, retinitis, chorioiditis, panuveitis, pars plani-
tis, and hyalitis. The clinical manifestations of 
ophthalmic brucellosis include injection, blurred 
vision, eye pain, tearing, diplopia, foreign body 
sensation, cotton-wool lesions, exudative retinal 
detachment, and retinal hemorrhage.
1-5 There are 
two explanations towards the pathogenesis of oph-
thalmic brucellosis including direct presence of 
brucellae and immune complexes depended path-
ogenesis.
2,4,6 
Rolando  et al. (2008) described two different 
types eye involvement compromising ophthalmo-
logic and neurophthalmologic ones.
2 Puig Solanes 
et al. (1953) described that among 60 patients with 
ophthalmic complication of brucellosis, 48 were 
with neurophthalmic involvement.
3 In majority of 
studies, uveitis has been considered as the most 
frequent form of ophthalmic involvement and pos-
terior uveitis was the most common form of uvei-
tis.
2,3,6,7 However, there is only one report in which 
conjunctivitis is shown to be the most common 
clinical form of ophthalmic brucellosis.
8  
The appearance of eye involvement in most 
cases of disease occurs during the chronic phase 
of brucellosis.
2,3,8 Our patient also developed 
uveitis during the chronic phase of brucellosis, a 
finding consistent with data of other studies. This 
is the first report of ophthalmic brucellosis in 
Qazvin Province as a bilateral involvement. The 
patient was a 45-year old man with fever, chills, 
and anorexia lasting for the last three months. He 
gave the history of consuming unpasteurized 
milk and cheese. Slight blurred vision of ten days 
duration was present at the time of the first medi-
cal appointment. The vital signs were stable. Fe-
ver, backache and arthralgia were the only main 
complications. The results of primary laboratory 
tests were SAT: 1/320, and Coomb’s Wright: 
1/640.  
Anti-brucellosis therapy was initiated by ad-
ministration of doxycycline (100 mg/12 hr) and 
rifampin (300 mg/12 hr). A week later, the patient 
returned because of the severity of blurred vision 
and floater. On ophthalmologic examination, pos-
terior uveitis as choroiditis, signs of vitritis and the 
presence of inflammatory cells within the vitrea at 
a range of 1
+ were reported while the retina, con-
junctivae, optic disk, and intra-ocular pressure 
were described as normal. The vision of both eyes 
following its best correction was at a limit of 8/10. 
The following tests were requested and the results 
reported were negative for PPD, VDRL, FTAABS, 
RF, ANA, and anti-toxoplasma Ab (IgM, IgG) as 
well as normal chest X ray (CXR).  
Considering the positive serologic tests for 
brucellosis and rejection of other causes of uvei-
tis, the patient was diagnosed as an ophthalmic 
brucellosis and therefore, in addition to anti-
brucellosis therapy, prednisolone at a daily dose 
of 50 mg was also administered. After 10 days, 
the patient’s vision improved considerably and Ophthalmic brucellosis 
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after day 14,  prednisolone dose was tapered and 
discontinued within 3 weeks while anti-
brucellosis treatment continued for 8 weeks. Oph-
thalmologic re-examination a month following recov-
ery was indicative of significant improvement of uve-
itis. The patient’s vision increased to 10/10. At the 
end of treatment, the patient was free of any clinical 
signs and symptoms, also with no signs of recurrent 
brucellosis and eye involvement after one-year fol-
low-up. 
The most common symptom of ophthalmic brucel-
losis was blurred vision that in most cases occurs bilat-
erally. In a study by Rolando et al., it was demonstrat-
ed that among 52 patients with signs of ophthalmic 
brucellosis, 69.2% were with blurred vision. Interest-
ingly, 19.3% of patients with no obvious ophthalmic 
symptoms had abnormal sight and pathologic findings 
when subjected to ophthalmologic examinations.
2 
Diagnosis of ophthalmic brucellosis is made 
through clinical ophthalmic examinations and labor-
atory tests including standard agglutination tests 
(SAT), Coomb’s Wright/SAT, 2ME, blood culture, 
and bone marrow culture. In some cases, aspiration 
of intraocular fluids followed by culture and serolo-
gy and biopsy may be necessary.
2,5,6 In our patient 
with uveitis, the confirmed diagnosis was serologi-
cally performed through positive results for   
anti-brucella antibodies while rejecting the other 
common causes of uveitis. 
Patients with posterior uveitis or panuveitis have a 
poor prognosis.
9 The major complications of oph-
thalmic brucellosis include reduced vision and blind-
ness of various degrees, cataract, glaucoma, macu-
lopathy, viteral alteration, retinal neovascular mem-
brane, tractional retinal detachment, and phthisis 
bulbi.
2-4,8,10-12  
Standard treatment with administration of rifampin 
and doxycycline and in case of eye involvement with 
local and systemic corticosteroide for 2-4 weeks leads 
to considerable improvement.
4,5,12  
Uveitis is the most common form of eye involve-
ment and therefore, patients with uveitis in endemic 
areas for brucellosis should also be investigated for 
brucellosis. Since the patients with no ophthalmic 
symptoms still may have ophthalmic involvement, it 
is recommended that in endemic areas patients with 
systemic brucellosis should be thoroughly examined 
for ophthalmic involvement. 
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